News Archiv


Workshop Review TIAFT 2019: Drogenanalytik

Auf der TIAFT 2019 in Birmingham hat Chromsystems einen Aussteller-Workshop über die Droganalytik organisiert. Referenten waren Dr. Lewis Couchman und Dr. Christoph Geffert, die über ihre Erfahrungen und Datenauswertungen mit unserem LC-MS/MS Assay zur Drogenanalytik berichtet haben.


Workshop Review - DoA and Antibiotics

Chromsystems Workshop at Analytica 2018: Drugs of abuse testing from screening to confirmation with speaker Katja Ackermann, MVZ Labor 28 (Berlin) and Dr Christoph Geffert from Labor Staber Dresden-Klipphausen. TDM of antibiotics with speaker Prof. Holdenrieder at the German Heart Centre (Munich) and Dr Heike Schneider from the Klinikum rechts der Isar (Munich).


New Product: Multilevel Calibrators and Controls for COVID-19 Drug Candidates 

Customers can use this protocol on a research-use basis, which demonstrates the analysis of more than 200 drugs plus immunosuppressants in the laboratory while also eliminating the need for changes to the chromatographic setup.


App Note: COVID-19 Drugs by LC-MS/MS with Series A

Researchers are working furiously to test a variety of potential drugs to find a suitable treatment for COVID-19, the disease caused by SARS-CoV-2. For this quest, Chromsystems developed a protocol for the drug monitoring of 9 drug candidates with MassTox® TDM Series A.


Scientific Paper: Vitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2

A new study investigated the potential relationship between vitamin D blood concentrations and SARS-CoV-2 infections. Is the risk of an infection and the disease severity influenced by the vitamin D status? The scientists used the MassChrom® Vitamin D assay on a MassSTAR automation system.


New Product: Vitamin B1 and B6 in Whole Blood by LC-MS/MS

A new mass spectrometry assay from Chromsystems allows the determination of the active forms of vitamin B1 (TPP) and vitamin B6 (PLP) in whole blood by LC-MS/MS.


List: Metabolism Disorders in Amino Acid Profile

This table features exemplary amino acid metabolism disorders and associated changes in the amino acid profile that are covered by the MassChrom Amino Acid Analysis (AAA) assay.


New Labels: Chromsystems is updating its product labels to include UDI

We are already integrating the new UDI code on our labels as part of the Unique Device Identification (UDI) System. UDIs are required only in the United States so far, but will become mandatory in Europe when the new IVDR comes into effect.


Article: Drugs of Abuse Testing with LC-MS/MS

In this article we compare LC-MS/MS with GC-MS currently considered as gold standard. The benefits of LC-MS/MS are demonstrated and it is shown how a 100% hydrolysis of glucuroniated drugs can be achieved. 


App Note: COVID-19 Drugs by LC-MS/MS with Series A

Researchers are working furiously to test a variety of potential drugs to find a suitable treatment for COVID-19, the disease caused by SARS-CoV-2. For this quest, Chromsystems developed a protocol for the drug monitoring of 9 drug candidates with MassTox® TDM Series A.